4-[(3R)-3-aminopyrrolidin-1-yl]-8-methyl-6,7,8,9-tetrahydro[1]benzofuro[3,2-d]pyrimidin-2-amine | 1132692-43-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 英文名称: 4-[(3R)-3-aminopyrrolidin-1-yl]-8-methyl-6,7,8,9-tetrahydro[1]benzofuro[3,2-d]pyrimidin-2-amine
• 英文别名: 4-[(3R)-3-aminopyrrolidin-1-yl]-8-methyl-6,7,8,9-tetrahydro-[1]benzofuro[3,2-d]pyrimidin-2-amine
• CAS: 1132692-43-3
• 化学式: C₁₅H₂₁N₅O
• 分子量: 287.365
• InChiKey: GEGWRFPKSVTPKT-YGPZHTELSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  21
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  94.2
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Thieno-and furo-pyrimidine modulators of the histamine H4 receptor
  申请人：Edwards James P.

  公开号：US20090075970A1

  公开（公告）日：2009-03-19

  Thieno- and furo-pyrimidine compounds are described, which are useful as H 4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H 4 receptor activity and for the treatment of disease states, disorders, and conditions mediated by H 4 receptor activity, such as inflammation.

  描述了噻吩-和呋喃-嘧啶化合物，这些化合物可用作H4受体调节剂。这些化合物可以用于制药组合物和用于调节组胺H4受体活性以及治疗由H4受体活性介导的疾病状态、紊乱和条件的方法，如炎症。
• Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
  申请人：Desmadryl Gilles

  公开号：US20120039913A1

  公开（公告）日：2012-02-16

  The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.

  该发明涉及组胺H4受体拮抗剂或组胺H4受体基因表达抑制剂，用于治疗和/或预防前庭障碍。
• THIENO- AND FURO-PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
  申请人：Edwards James P.

  公开号：US20120270855A1

  公开（公告）日：2012-10-25

  Thieno- and furo-pyrimidine compounds are described, which are useful as H 4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H 4 receptor activity and for the treatment of disease states, disorders, and conditions mediated by H 4 receptor activity, such as inflammation.

  本文描述了一种噻吩和呋喃嘧啶化合物，可用作H4受体调节剂。这些化合物可用于制备药物组合物和方法，用于调节组胺H4受体活性和治疗由H4受体活性介导的疾病状态、障碍和病况，如炎症。
• THIENO- ADN FURO-PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
  申请人：Edwards James P.

  公开号：US20120214792A1

  公开（公告）日：2012-08-23

  Thieno- and furo-pyrimidine compounds are described, which are useful as H 4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H 4 receptor activity and for the treatment of disease states, disorders, and conditions mediated by H 4 receptor activity, such as inflammation.

  本文描述了噻吩和呋喃嘧啶化合物，可用作H4受体调节剂。这些化合物可用于制备药物组合物和方法，以调节组胺H4受体活性，并用于治疗由H4受体活性介导的疾病状态、障碍和病情，例如炎症。
• SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS
  申请人：INSERM (Institut National de la Santé et de la Recherche Médicale)

  公开号：EP3130376A1

  公开（公告）日：2017-02-15

  The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.

  本发明涉及组胺 H4 受体拮抗剂或组胺 H4 受体基因表达抑制剂，用于治疗和/或预防前庭失调。